Plain-English translation of NCT07669519 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing whether a supplement called Nuvastatic can help reduce the severe tiredness that many colon cancer patients experience during chemotherapy. Cancer-related fatigue is one of the most difficult side effects to manage, and this medication is designed to help you feel more energetic and functional during your treatment. Half of participants will receive the active treatment, and half will receive a placebo (inactive pill), to see if the medication truly makes a difference.
Many colon cancer patients struggle with overwhelming fatigue during chemotherapy, which can make daily life very difficult and interfere with treatment. Right now, there are limited options to help with this problem, so researchers want to find out if this medication can safely and effectively reduce this exhausting side effect.
You likely qualify if…
You likely don't qualify if…
You will take sachets (powder packets) of either the medication or placebo three times daily for about 60 days total, divided into three 20-day cycles, while you continue your regular chemotherapy. You will continue attending your normal cancer treatment appointments and will provide blood samples at the start and end of the study so researchers can track certain markers. You will also complete fatigue diaries and regular fatigue questionnaires so the research team can see if the treatment is helping you feel less tired.
AI-generated summary from trial data · Aug 29, 2026 · Not medical advice
India